GelSana Hires Chief Commercial Officer
Medtech Industry Veteran joins GelSana as Chief Commercial Officer (AURORA, CO) – January 09, 2026 – GelSana Therapeutics, Inc. (“GelSana”), a wound care company developing novel polymer-based dressings to accelerate healing, today announced that Donald Gregg has joined the company... Read More →
PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data
PharmaJet’s intramuscular (IM) Needle-free Injection System – Stratis® – was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. The Scancell immunotherapy delivered using PharmaJet’s Stratis demonstrated a Progression-Free Survival... Read More →
AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0
Newly cleared AccurECG 2.0 is enterprise-grade, device-agnostic ECG interpretation platform designed for scale, accelerated turnaround, and flexible customer integrations. NEW YORK–(BUSINESS WIRE)–AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad... Read More →
FineHeart secures €83 million to support its growth
Bordeaux, France – January 8, 2026 – FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced today the completion of a €35 million first closing of its Series C financing round. This funding... Read More →
Prevencio and Quadrant Health Announce Partnership to Integrate HART CVE and HART CADhs AI-Blood Tests into Primary Care
Partnership expands access to AI cardiometabolic risk insights to support earlier detection, clearer triage, and more personalized care pathways KIRKLAND, WA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — Prevencio, Inc., a leader in advanced, AI-driven multiprotein-based cardiovascular and cardiometabolic risk... Read More →
BRIJ Medical Oversubscribes Recent Fundraising Round Ahead of Expansion and Next-Gen Product Launch
MARIETTA, Ga., Jan. 8, 2026 /PRNewswire/ — BRIJ Medical, the company redefining surgical closure and post-surgical healing with active tension offloading, today announced that it has successfully oversubscribed its SAFE fundraising round, surpassing its initial target amid strong investor demand.... Read More →
TYBR Health’s B3 GEL System Makes its Clinical Debut in U.S.
Dr. Hanna Tammam, a fellowship-trained hand, elbow, and shoulder surgeon in Lubbock, Texas, is the first U.S. physician to use TYBR Health’s B3 GEL System in a procedure, the company announced. B3 GEL is a collagen-based tissue protector derived from... Read More →
How Inflammatix’s TriVerity supports faster infection diagnosis
MOBILE, Ala. (WKRG) — USA Health recently became the first and only hospital in the state of Alabama to implement a breakthrough blood test to quickly identify and treat sepsis. Dr. Edward Panacek, chair of emergency medicine at USA Health,... Read More →
FDA Clears BrainSpace Intellidrop, an automated neuro device that addresses ICU nursing shortages and builds training data for Physical AI
SEATTLE, Jan. 2, 2026 /PRNewswire/ — BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Intellidrop, an automated brain fluid... Read More →
FDA Clears BrainSpace Intellidrop, an automated neuro device that addresses ICU nursing shortages and builds training data for Physical AI
SEATTLE, Jan. 2, 2026 /PRNewswire/ — BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Intellidrop, an automated brain fluid... Read More →